(Q37962571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Global epigenetic profiling in bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ewa Dudziec

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

John R Goepel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

35-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

cites work

Cancer statistics, 2010

1 reference

Clinical model of lifetime cost of treating bladder cancer and associated complications

21 January 2018

1 reference

The economic consequences of prostate and bladder cancer in the UK.

21 January 2018

1 reference

Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium

21 January 2018

1 reference

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

21 January 2018

1 reference

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.

21 January 2018

1 reference

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

21 January 2018

1 reference

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

21 January 2018

1 reference

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.

21 January 2018

1 reference

Distinct microRNA alterations characterize high- and low-grade bladder cancer

21 January 2018

1 reference

Promoter hypermethylation identifies progression risk in bladder cancer.

21 January 2018

1 reference

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

21 January 2018

1 reference

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1.

21 January 2018

1 reference

Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter

21 January 2018

1 reference

MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin

21 January 2018

1 reference

Induction of Tumors in Mice by Genomic Hypomethylation

21 January 2018

1 reference

LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability

21 January 2018

1 reference

Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells

21 January 2018

1 reference

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.

21 January 2018

1 reference

Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer

21 January 2018

1 reference

Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.

21 January 2018

1 reference

Identification of methylated genes associated with aggressive bladder cancer

21 January 2018

1 reference

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

21 January 2018

1 reference

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.

21 January 2018

1 reference

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

21 January 2018

1 reference

Discovery of myopodin methylation in bladder cancer.

21 January 2018

1 reference

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression

21 January 2018

1 reference

Examination of IGF2 and H19 loss of imprinting in bladder cancer.

21 January 2018

1 reference

Implications of LINE1 methylation for bladder cancer risk in women

21 January 2018

1 reference

Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer

21 January 2018

1 reference

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study

21 January 2018

1 reference

Chromatin modifications and their function

21 January 2018

1 reference

Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells

21 January 2018

1 reference

Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin

21 January 2018

1 reference

Suz12 binds to silenced regions of the genome in a cell-type-specific manner

21 January 2018

1 reference

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

21 January 2018

1 reference

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

21 January 2018

1 reference

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

21 January 2018

1 reference

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

21 January 2018

1 reference

Regulated demethylation of the myoD distal enhancer during skeletal myogenesis

21 January 2018

1 reference

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 January 2018

1 reference

Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes

21 January 2018

1 reference

Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells

21 January 2018

1 reference

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer

21 January 2018

1 reference

Identification of PMF1 methylation in association with bladder cancer progression

21 January 2018

1 reference

Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes

21 January 2018

1 reference

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition

21 January 2018

1 reference

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

21 January 2018

1 reference

Advances in genome-wide DNA methylation analysis

21 January 2018

1 reference

Genome-wide high throughput analysis of DNA methylation in eukaryotes

21 January 2018

1 reference

ChIP-seq: advantages and challenges of a maturing technology

21 January 2018

1 reference

The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

21 January 2018

1 reference

Human DNA methylomes at base resolution show widespread epigenomic differences

21 January 2018

1 reference

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

21 January 2018

1 reference

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

21 January 2018

1 reference

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

21 January 2018

1 reference

Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder.

21 January 2018

1 reference

XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome

21 January 2018

1 reference

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

21 January 2018

1 reference

Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer

21 January 2018

1 reference

Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes

21 January 2018

1 reference

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays

21 January 2018

1 reference

MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.

21 January 2018

1 reference

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

21 January 2018

1 reference

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

21 January 2018

1 reference

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

21 January 2018

1 reference

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

Behavior of Urothelial Carcinoma With Respect to Anatomical Location

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/EPI.10.71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22126151%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference